Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction

Mehrangiz Dezhbord, Seong Ho Kim, Soree Park, Da Rae Lee, Nayeon Kim, Juhee Won, Ah Ram Lee, Dong-Sik Kim, Kyun-Hwan Kim

Clin Mol Hepatol. 2024;30(3):539-560. Published online May 14, 2024

DOI: https://doi.org/10.3350/cmh.2024.0060

View: 1156 Download: 169

Reply to Correspondence

Correspondence on Letter regarding “Both liver parenchymal and non-parenchymal cells express JCAD proteins under various circumstances”

Byoung Kuk Jang

Clin Mol Hepatol. 2024;30(2):297-298. Published online April 1, 2024

DOI: https://doi.org/10.3350/cmh.2024.0210

View: 1624 Download: 25

Correspondence

Both liver parenchymal and non-parenchymal cells express JCAD protein under various circumstances

Li Xie, Li Zhang, Hui Chen, Yong-Yu Yang, Jian Wu

Clin Mol Hepatol. 2024;30(2):279-280. Published online March 20, 2024

DOI: https://doi.org/10.3350/cmh.2024.0191

View: 1839 Download: 46 Web of Science: 1 Crossref: 1

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Hepatic Hippo signaling inhibits development of hepatocellular carcinoma

Yuchen Liu, Xiaohui Wang, Yingzi Yang

Clin Mol Hepatol. 2020;26(4):742-750. Published online September 28, 2020

DOI: https://doi.org/10.3350/cmh.2020.0178

View: 7937 Download: 206 Web of Science: 36 Crossref: 36

Emerging medical therapies for severe alcoholic hepatitis

David Tornai, Gyongyi Szabo

Clin Mol Hepatol. 2020;26(4):686-696. Published online September 28, 2020

DOI: https://doi.org/10.3350/cmh.2020.0145

View: 6277 Download: 222 Web of Science: 16 Crossref: 16

2

Clinical application of stem cells in Liver diseases

Si Hyun Bae

Clin Mol Hepatol. 2008;14(3):309-317. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.309

View: 6532 Download: 96 Crossref: 9

Hepatitis B Virus Surface Antigen: A Multifaceted Protein

Jung Hyun Park

Clin Mol Hepatol. 2004;10(4):248-259.

View: 2686 Download: 28

3

Isolation and Culture of Pig Hepatocyte in Large Scale for the Application of Bioartificial Liver System

Yu Jeong Chung Hyuk-Joon Lee Young Taeg Koh Sang Beom Kim , Seong Hoon Kim Seokho Choi Nam-Joon Yi Seong-Hwan Chang Eun Lan Yang Kyung-Suk Suh Yoon Shin Lee , and Kuhn Uk Lee

Clin Mol Hepatol. 2002;8(3):249-255. Published online January 1, 2000

View: 2697 Download: 23

Freezing and Tbawing Conditioras of Rat Heqatocytes

Seong Gyu Hwang, M.D.*†, Eun Mi Jung, M.D.*, Seong Wook Oh, M.D.*, Chang Il Kwon, M.D.*, Kyung Chul Kim, M.D.*, Sung Pyo Hong, M.D.*†, Pil Won Park, M.D.*, and Kyu Sung Rim, M.D.*†

Clin Mol Hepatol. 2001;7(3):308-314. Published online January 1, 2000

View: 2155 Download: 18

Protective Effect of Cholesteryl Hemisuccinate on Fumonisin B1-Induced Apoptosis of Hepatocytes in the Rat Liver

Woo Sung Moon, M.D. Chul Kyu Park, M.D. Myoung Jae Kang, M. D. Dong Geun Lee, M.D. Ho Yeul Choi, M.D.

Clin Mol Hepatol. 1999;5(3):227-239. Published online January 1, 2000

View: 2129 Download: 13

Effect of Intrasplenic Transplantation of Cryopreserved Hepatocytes into Partially Hepatectomized Rats

Seong Gyu Hwang, M.D., Ik Jin Yun, M.D. Yun Soo Kim, M.D. Kyung Chul Kim, M.D., Sung Pyo Hong, M.D., Pil Won Park, M.D., Kyu Sung Rim, M.D., Joo Young Cho, M.D. Joon Seong Lee, M.D. Moon Sung Lee, M.D. and Chan Sup Shim, M.D.

Clin Mol Hepatol. 1999;5(2):116-123. Published online January 1, 2000

View: 2058 Download: 15

In vitro Induction of Cellular Differentiation of Human Fetal Liver Cell Lines with Sodium Butyrate

Jung Hwan Yoon , June Sung Lee , Hyo Suk Lee , Chung Yong Kim

Clin Mol Hepatol. 1997;3(3):193-201. Published online January 1, 1970

View: 2147 Download: 14

2

Nonsurgical Management of Fulmninant Hepatic Failure - Hepatocyte transplantation and bioartificial liver -

Byung Ho Kim

Clin Mol Hepatol. 1996;2(2):116-128.

View: 2637 Download: 15

1 |

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5405	MAFLD: How is it different from NAFLD?
Viewed By 5215	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5095	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4727	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search